Gui L - Search Results

1

RNA interference-mediated downregulation of phospholipid scramblase 1 expression in primary liver cancer in vitro.

Gui L, Zhu YW, Xu Q, Huang JJ, Hua P, Wu GJ, Lu J, Ni JB, Tang H, Zhang LL. Gui L, et al. Oncol Lett. 2020 Dec;20(6):361. doi: 10.3892/ol.2020.12225. Epub 2020 Oct 14. Oncol Lett. 2020. PMID: 33133261 Free PMC article.

2

CYP2J2 promotes the development of hepatocellular carcinoma by increasing the EETs production to improve HIF-1α stability.

Gui L, Xu Q, Huang J, Wu G, Tang H, Hui L, Hua P, Zhang L, Zhu Y. Gui L, et al. Am J Transl Res. 2020 Dec 15;12(12):7923-7937. eCollection 2020. Am J Transl Res. 2020. PMID: 33437370 Free PMC article.

3

Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.

Zhang CH, Zheng L, Gui L, Lin JY, Zhu YM, Deng WS, Luo M. Zhang CH, et al. Among authors: gui l. Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):118-125. doi: 10.1016/j.clinre.2017.09.001. Epub 2017 Oct 12. Clin Res Hepatol Gastroenterol. 2018. PMID: 29031875

4

UBE2S promotes cell chemoresistance through PTEN-AKT signaling in hepatocellular carcinoma.

Gui L, Zhang S, Xu Y, Zhang H, Zhu Y, Kong L. Gui L, et al. Cell Death Discov. 2021 Nov 16;7(1):357. doi: 10.1038/s41420-021-00750-3. Cell Death Discov. 2021. PMID: 34785642 Free PMC article.

5

The influence of local therapy on the survival of patients with metastatic rectal cancer: a population-based, propensity-matched study.

Zhang CH, Pan YB, Zhang QW, Shi OM, Zheng L, Gui L, Luo M. Zhang CH, et al. Among authors: gui l. J Cancer Res Clin Oncol. 2017 Sep;143(9):1891-1903. doi: 10.1007/s00432-017-2442-2. Epub 2017 May 22. J Cancer Res Clin Oncol. 2017. PMID: 28534172

6

Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.

Lv H, Zhang Z, Wu X, Wang Y, Li C, Gong W, Gui L, Wang X. Lv H, et al. Among authors: gui l. PLoS One. 2016 Jan 4;11(1):e0145195. doi: 10.1371/journal.pone.0145195. eCollection 2016. PLoS One. 2016. PMID: 26727592 Free PMC article.

7

Corrigendum to "ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia" [Materials Today Bio 13(2022) 100192].

Gui L, Chen Y, Diao Y, Chen Z, Duan J, Liang X, Li H, Liu K, Miao Y, Gao Q, Li Z, Yang J, Li Y. Gui L, et al. Mater Today Bio. 2022 Mar 17;14:100242. doi: 10.1016/j.mtbio.2022.100242. eCollection 2022 Mar. Mater Today Bio. 2022. PMID: 35694208 Free PMC article.

8

ROS-responsive nanoparticle-mediated delivery of CYP2J2 gene for therapeutic angiogenesis in severe hindlimb ischemia.

Gui L, Chen Y, Diao Y, Chen Z, Duan J, Liang X, Li H, Liu K, Miao Y, Gao Q, Li Z, Yang J, Li Y. Gui L, et al. Mater Today Bio. 2021 Dec 20;13:100192. doi: 10.1016/j.mtbio.2021.100192. eCollection 2022 Jan. Mater Today Bio. 2021. PMID: 34988419 Free PMC article.

9

ROS-responsive capsules engineered from EGCG-Zinc networks improve therapeutic angiogenesis in mouse limb ischemia.

Chen Z, Duan J, Diao Y, Chen Y, Liang X, Li H, Miao Y, Gao Q, Gui L, Wang X, Yang J, Li Y. Chen Z, et al. Among authors: gui l. Bioact Mater. 2020 Aug 7;6(1):1-11. doi: 10.1016/j.bioactmat.2020.07.013. eCollection 2021 Jan. Bioact Mater. 2020. PMID: 32817909 Free PMC article.

10

Laparoscopic Common Bile Duct Exploration Versus Open Approach in Cirrhotic Patients with Choledocholithiasis: A Retrospective Study.

Gui L, Liu Y, Qin J, Zheng L, Huang YJ, He Y, Deng WS, Qian BB, Luo M. Gui L, et al. J Laparoendosc Adv Surg Tech A. 2016 Dec;26(12):972-977. doi: 10.1089/lap.2016.0308. Epub 2016 Aug 10. J Laparoendosc Adv Surg Tech A. 2016. PMID: 27509535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,140 results

Search Page

Filters